COMMUNITY ACQUIRED INFECTION

COMMUNITY ACQUIRED INFECTION was reported 56 times

COMMUNITY ACQUIRED INFECTION is most prevalent among patients taking these drug classes:

# Drug class Count Frequency
0 Macrolide Antibacterial [EPC] 1 0.0010
1 Selective T Cell Costimulation Blocker [EPC] 1 0.0002
2 Hydrolytic Lysosomal Glycosaminoglycan-specific Enzyme [EPC] 1 0.0001
3 General Anesthetic [EPC] 2 0.0000
4 Bile Acid [EPC] 1 0.0000
5 Prostacyclin Receptor Agonist [EPC] 1 0.0000
6 Macrolide Antimicrobial [EPC] 2 0.0000
7 Interleukin-17A Antagonist [EPC] 1 0.0000
8 Aminoglycoside Antibacterial [EPC] 1 0.0000
9 Erythropoiesis-stimulating Agent [EPC] 1 0.0000
10 Peroxisome Proliferator Receptor alpha Agonist [EPC] 1 0.0000
11 Herpesvirus Nucleoside Analog DNA Polymerase Inhibitor [EPC] 2 0.0000
12 Herpes Simplex Virus Nucleoside Analog DNA Polymerase Inhibitor [EPC] 2 0.0000
13 Nitroimidazole Antimicrobial [EPC] 1 0.0000
14 Topoisomerase Inhibitor [EPC] 1 0.0000
15 Aldosterone Antagonist [EPC] 2 0.0000
16 Azole Antifungal [EPC] 2 0.0000
17 Alkylating Drug [EPC] 3 0.0000
18 Corticosteroid [EPC] 12 0.0000
19 Fluoroquinolone Antibacterial [EPC] 1 0.0000
20 Calcineurin Inhibitor Immunosuppressant [EPC] 1 0.0000
21 Nucleoside Metabolic Inhibitor [EPC] 2 0.0000
22 Angiotensin 2 Receptor Blocker [EPC] 2 0.0000
23 Xanthine Oxidase Inhibitor [EPC] 1 0.0000
24 RANK Ligand Inhibitor [EPC] 1 0.0000
25 Folate Analog Metabolic Inhibitor [EPC] 2 0.0000
26 Insulin Analog [EPC] 2 0.0000
27 Loop Diuretic [EPC] 2 0.0000
28 Platinum-based Drug [EPC] 1 0.0000
29 Factor Xa Inhibitor [EPC] 1 0.0000
30 Platelet Aggregation Inhibitor [EPC] 2 0.0000
31 Osmotic Laxative [EPC] 1 0.0000
32 beta-Adrenergic Blocker [EPC] 1 0.0000
33 CD20-directed Cytolytic Antibody [EPC] 1 0.0000
34 Dihydropyridine Calcium Channel Blocker [EPC] 1 0.0000
35 HMG-CoA Reductase Inhibitor [EPC] 1 0.0000
36 Nonsteroidal Anti-inflammatory Drug [EPC] 3 0.0000
37 Atypical Antipsychotic [EPC] 1 0.0000
38 Thalidomide Analog [EPC] 1 0.0000
39 Proton Pump Inhibitor [EPC] 1 0.0000